← Open Payments lookup

DAMARIS KIPTOO: Open Payments

NPI 1104667591 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$604 in 13 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $604

Food & beverage: $517Education: $87
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.1$150
Rigel Pharmaceuticals, Inc.1$119
Daiichi Sankyo Inc.1$87
Exelixis Inc.2$79
AstraZeneca Pharmaceuticals LP2$48
Celgene Corporation1$26
Genentech USA, Inc.1$24
Genmab U.S., Inc.1$20
ARRAY BIOPHARMA INC1$19
Incyte Corporation1$18

Products named: BREYANZI, REZLIDHIA, Enhertu, CABOMETYX, REBLOZYL, CALQUENCE, Itovebi, IMFINZI.

Industry payments across NV — which companies pay providers there.